Mo 2016.

Methods	Design: parallel RCT Randomisation method: random number table Blinding: no Power calculation: no Dropouts/withdrawals: no
Participants	Cancer patients after chemotherapy with expected survival time of more than 6 months, Karnofsky ≥ 60, and WBC count less than 4 × 109/L; diagnosed with the Chinese medicine syndrome of qi and blood insufficiency Number (treatment/control): 82 (41/41) Mean age (range): 55.5 (34‐69) Gender (M/F): 48/34 Country: Guangdong province, China Setting: hospital
Interventions	Moxa stick vs conventional medicine Treatment group Moxa stick Moxa stick on the acupoints RN4 (guanyuan), RN8 (shenque), RN6 (qihai) and bilateral ST36 (zusanli), once per day, 20 minutes each treatment, 6 times per week Treatment duration: 21 days Control group conventional medicine Oral batilol 40 mg, 3/d and leucogen 20 mg, 3/d Treatment duration: 21 days
Outcomes	WBC count and Karnofsky score at the end of treatment
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	Random number table
Allocation concealment (selection bias)	Unclear risk	No relevant description
Incomplete outcome data (attrition bias) All outcomes	Low risk	There was no loss to follow‐up. All participants were included in the analysis.
Selective reporting (reporting bias)	Unclear risk	Limited outcome measures were reported.
Other bias	Unclear risk	There was no statement about group similarity.
Blinding of participants and personnel (performance bias) All outcomes	High risk	No blinding
Blinding of outcome assessment (detection bias) Subjective outcomes	High risk	No blinding
Blinding of outcome assessment (detection bias) Objective outcomes	Low risk	No blinding; however, machine‐measured objective outcomes were not influenced substantially